NCT02880215

Brief Summary

Although negatively biased attention has a central theoretical and empirical role in the maintenance of depression, there are few behavioral treatments that successfully target and improve this deficit. The current proposal builds upon prior work and aims to further develop an attention bias modification intervention. The investigators propose to develop a highly specific intervention that directly targets negative attention bias and the neurobiology that supports it, using cutting-edge cognitive neuroscience to inform treatment development and improve quality of life of patients whose psychopathology is maintained by negative attention bias.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 26, 2016

Completed
1 year until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2019

Completed
Last Updated

October 16, 2019

Status Verified

October 1, 2019

Enrollment Period

2.1 years

First QC Date

August 17, 2016

Last Update Submit

October 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quick Inventory of Depression - Self Report (QIDS-SR)

    16-item self-report measure of depression symptom severity

    Change in QIDS-SR from baseline to Week 4 to measure change in self-reported depression.

Secondary Outcomes (2)

  • Mood and Anxiety Symptoms Questionnaire-Short Form (MASQ-SF)

    Change in MASQ-SF from baseline to Week 4 to measure change in self-reported depression.

  • Hamilton Depression Rating Scale - 17 Item (HAMD-17)

    Change in HAMD-17 from baseline to Week 4 to measure change in interviewer-rated depression.

Other Outcomes (3)

  • Attention bias (eye tracking)

    Change in attention bias from baseline to Week 4 to measure change in negative attention bias.

  • Resting State (fMRI)

    Change in resting state fMRI from baseline to Week 4 to measure change connectivity in frontal-parietal brain circuitry.

  • Psychomotor vigilance test (PVT)

    Change in PVT from baseline to Week 4 to measure change in sustained attention.

Study Arms (3)

Attention Bias Modification

EXPERIMENTAL

Behavioral intervention designed to improved negative attention bias.

Behavioral: Attention Bias Modification

Cognitive Control Training

EXPERIMENTAL

Behavioral intervention designed to improve sustained attention.

Behavioral: Cognitive Control Training

Assessment Only

NO INTERVENTION

Assessment only with no active intervention.

Interventions

Behavioral intervention designed to decrease negative attention bias.

Attention Bias Modification

Behavioral intervention designed to improve sustained attention.

Cognitive Control Training

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • able and willing to provide informed consent;
  • fluent in English;
  • moderate or greater depression symptoms;
  • attention bias for negative stimuli;
  • stable psychiatric and neurological medication usage.

You may not qualify if:

  • meets criteria for current substance use disorder (mild or greater severity), current or past psychotic disorder, bipolar disorder, or schizophrenia;
  • has any medical or physical conditions that would preclude participation in an fMRI study (e.g., orthodontic braces);
  • is currently receiving psychotherapy or electroconvulsive therapy (ECT);
  • current opioid analgesics or systemic corticosteroid use for an acute medical condition or taken as needed;
  • has had suicidal behaviors or significant suicidal ideation within the last six months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mood Disorders Laboratory

Austin, Texas, 78712, United States

Location

Related Publications (2)

  • Beevers CG, Clasen PC, Enock PM, Schnyer DM. Attention bias modification for major depressive disorder: Effects on attention bias, resting state connectivity, and symptom change. J Abnorm Psychol. 2015 Aug;124(3):463-75. doi: 10.1037/abn0000049.

  • Beevers CG, Hsu KJ, Schnyer DM, Smits JAJ, Shumake J. Change in negative attention bias mediates the association between attention bias modification training and depression symptom improvement. J Consult Clin Psychol. 2021 Oct;89(10):816-829. doi: 10.1037/ccp0000683.

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Director of the Institute for Mental Health Research

Study Record Dates

First Submitted

August 17, 2016

First Posted

August 26, 2016

Study Start

September 1, 2017

Primary Completion

September 26, 2019

Study Completion

September 26, 2019

Last Updated

October 16, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will share

De-identified data will be made available upon study completion.

Locations